Serum cholesterol levels and survival after rtPA treatment in acute stroke

European Journal of Neurology

Volumn 19, Issue 4, 2012, Pages 648-654

  Roquer, J ^a,b   Cuadrado Godia, E ^a,b   Rodriguez Campello A ^a,b   Jimenez Conde J ^a,b   Martinez Rodriguez J E ^a,b   Giralt, E ^a,b   Ois, A ^a,b  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Acute stroke; Cholesterol; Lipids; Mortality; Outcome; RtPA; Stroke unit

Indexed keywords

ALTEPLASE; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE DISEASE; ADULT; AGE; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; DISEASE SEVERITY; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STROKE; SURVIVAL; TERTIARY HEALTH CARE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CEREBRAL HEMORRHAGE; CHOLESTEROL; COHORT STUDIES; FACTOR ANALYSIS, STATISTICAL; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84858337928     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03607.x     Document Type: Article

References (40)

1. Pekkanen J, Linn S, Heiss G, et al. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med 1990; 322: 1700-1707.
2. Prospective Studies Collaboration, Lewington S, Whitlock G, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55, 000 vascular deaths. Lancet 2007; 370: 1829-1839.
3. Willey JZ, Xu Q, Boden-Albala B, et al. Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS). Arch Neurol 2009; 66: 1400-1406.
4. Feigin VL, Rinkel GJ, Lawes CM, et al. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke 2005; 36: 2773-2780.
5. Sturgeon JD, Folsom AR, Longstreth WT Jr, Shahar E, Rosamond WD, Cushman M. Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke 2007; 38: 2718-2725.
6. Vauthey C, de Freitas GR, van Melle G, Devuyst G, Bogousslavsky J. Better outcome after stroke with higher serum cholesterol levels. Neurology 2000; 54: 1944-1949.
7. Cuadrado-Godia E, Jiménez-Conde J, Ois A, Rodriguez-Campello A, Garcia-Ramallo E, Roquer J. Gender differences in the prognostic value of lipid profile after the first ischemic stroke. J Neurol 2009; 256: 989-995.
8. Roquer J, Rodríguez-Campello A, Gomis M, Ois A, Munteis E, Böhm P. Serum lipid levels and in-hospital mortality in patients with intracerebral hemorrhage. Neurology 2005; 65: 1198-1202.
9. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, Wu DY. Reverse epidemiology: a spurious hypothesis or a hardcore reality? Blood Purif 2005; 23: 57-63.
10. Martí Fàbregas J, Gomis M, Arboix A, et al. Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke 2004; 35: 1117-1123.
11. Gomis M, Ois A, Rodríguez-Campello A, et al. Outcome of intracerebral hemorrhage patients pretreated with statins. Eur J Neurol 2010; 17: 443-448.
12. Alvarez-Sabin J, Huertas R, Quintana M, et al. Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator. Stroke 2007; 38: 1076-1078.
13. Miedema I, Uyttenboogaart M, Koopman K, De Keyser J, Luijckx GJ. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke. Cerebrovasc Dis 2010; 29: 263-267.
14. Meier N, Nedeltchev K, Brekenfeld C, et al. Prior statin use, intracranial hemorrhage, and outcome after intra-arterial thrombolysis for acute ischemic stroke. Stroke 2009; 40: 1729-1737.
15. Restrepo L, Bang OY, Ovbiagele B, et al. Impact of hyperlipidemia and statins on ischemic stroke outcomes after intra-arterial fibrinolysis and percutaneous mechanical embolectomy. Cerebrovasc Dis 2009; 28: 384-390.
16. Jimenez-Conde J, Biffi A, Rahman R, et al. Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke. Stroke 2010; 41: 437-442.
17. Ois A, Cuadrado-Godia E, Jiménez-Conde J, et al. Early arterial study in the prediction of mortality after acute ischemic stroke. Stroke 2007; 38: 2085-2089.
18. Larrue V, von Kummer R, del Zoppo G, Bluhmki E. Hemorrhagic transformation in acute ischemic stroke. Stroke 1997; 28: 957-960.
19. Roquer J, Rodríguez-Campello A, Gomis M. Sex differences in first-ever acute stroke. Stroke 2003; 34: 1581-1585.
20. Adams HP Jr, Davis PH, Leira EC, et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999; 53: 126-131.
21. Saxena R, Lewis S, Berge E, Sandercock PAG, Koudstaal PJ. Risk of early deathand recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the international stroke trial. Stroke 2001; 32: 2333-2337.
22. Ois A, Gomis M, Cuadrado-Godia E, et al. Heart failure in acute ischemic stroke. J Neurol 2008; 255: 385-389.
23. Roquer J, Ois A, Rodríguez-Campello A, et al. Atherosclerotic Burden and early mortality in acute ischemic stroke. Arch Neurol 2007; 64: 699-704.
24. Williams LS, Rotich J, Qi R, et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 2002; 59: 67-71.
25. Dyker AG, Weir CJ, Lees KR. Influence of cholesterol on survival after stroke: retrospective study. BMJ 1997; 314: 1584-1588.
26. Weir CJ, Sattar N, Walters MR, Lees KR. Low triglyceride, not low cholesterol concentration, independently predicts poor outcome following acute stroke. Cerebrovasc Dis 2003; 16: 76-82.
27. Saqqur M, Uchino K, Demchuk AM, et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007; 38: 948-954.
28. Ribo M, Alvarez-Sabín J, Montaner J, et al. Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques. Stroke 2006; 37: 1000-1004.
29. Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375: 1695-1703.
30. Wahlgren N, Ahmed N, Eriksson N, et al. Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy Investigators. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST). Stroke 2008; 39: 3316-3322.
31. de Lau LM, Koudstaal PJ, Hofman A, Breteler MM. Serum cholesterol levels and the risk of Parkinson's disease. Am J Epidemiol 2006; 164: 998-1002.
32. Vatassery GT, Smith WE, Quach HT, Lai CK. In vitro oxidation of vitamin E, vitamin C, thiols, and cholesterol in rat brain mitochondria incubated with free radicals. Neurochem Int 1995; 26: 527-535.
33. Rodriguez C, Slevin M, Rodriguez-Calvo R, et al. Modulation of endothelium and endothelial progenitor cell function by low-density lipoproteins: implication for vascular repair, angiogenesis and vasculogenesis. Pathobiology 2009; 76: 11-22.
34. Goritz C, Mauch DH, Pfrieger FW. Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron. Mol Cell Neurosci 2005; 29: 190-201.
35. Bohr IJ. Does cholesterol act as a protector of cholinergic projections in Alzheimer's disease? Lipids Health Dis 2005; 4: 13.
36. Pike L. Lipid rafts: bringing Order to Chaos. J Lipid Res 2003; 44: 655-667.
37. Björkhem I, Meaney S. Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol 2004; 24: 806-815.
38. Koper JW, Zeinstra EC, Lopes-Cardozo M, van Golde LM. Acetoacetate and glucose as substrates for lipid synthesis by rat brain oligodendrocytes and astrocytes in serum-free culture. Biochim Biophys Acta 1984; 796: 20-26.
39. Dehouck B, Fenart L, Dehouck MP, Pierce A, Torpier G, Cecchelli R. A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J Cell Biol 1997; 138: 877-889.
40. Olsen TS, Christensen RH, Kammersgaard LP, Andersen KK. Higher total serum cholesterol levels are associated with less severe strokes and lower all-cause mortality: ten-year follow-up of ischemic strokes in the Copenhagen Stroke Study. Stroke 2007; 38: 2646-2651.